Attached files
file | filename |
---|---|
EX-10.6 - EX-10.6 - Odonate Therapeutics, Inc. | d461398dex106.htm |
EX-10.4 - EX-10.4 - Odonate Therapeutics, Inc. | d461398dex104.htm |
EX-10.3 - EX-10.3 - Odonate Therapeutics, Inc. | d461398dex103.htm |
EX-10.2 - EX-10.2 - Odonate Therapeutics, Inc. | d461398dex102.htm |
EX-10.1 - EX-10.1 - Odonate Therapeutics, Inc. | d461398dex101.htm |
EX-5.1 - EX-5.1 - Odonate Therapeutics, Inc. | d461398dex51.htm |
EX-3.2 - EX-3.2 - Odonate Therapeutics, Inc. | d461398dex32.htm |
EX-3.1 - EX-3.1 - Odonate Therapeutics, Inc. | d461398dex31.htm |
EX-1.1 - EX-1.1 - Odonate Therapeutics, Inc. | d461398dex11.htm |
S-1/A - S-1/A - Odonate Therapeutics, Inc. | d461398ds1a.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement (No. 333-221533) on Form S-1 of Odonate Therapeutics, LLC of our report dated September 29, 2017, relating to the financial statements of Odonate Therapeutics, LLC, appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the headings Experts in such Prospectus.
/s/ SQUAR MILNER LLP
San Diego, California
November 27, 2017